加快推进中国式药品监管现代化——第六届中国药品监管科学大会观点综述

Accelerating Chinese-style Modernization of Drug Administration-An Overview of the 6th China Drug Regulatory Science Conference

为学习贯彻党的二十大精神,践行党中央关于药品监管工作的部署,在国家药品监督管理局指导和有关单位大力支持下,2023年4月1日,中国药品监督管理研究会在北京举办第六届中国药品监管科学大会。大会主题为“新征程、新任务、新机遇——监管科学助力监管能力建设和行业高质量发展”。国家药监局有关司局、直属单位和30个省(自治区、直辖市)药监局相关负责人以及来自全国医药科研单位、高等院校、医疗机构、制药企业和相关学会协会的代表参加会议。与会专家围绕全面提升药品监管能力、推动医药产业高质量发展、监管科学助力医药强国建设、服务保障疫情防控的重大成果、构建国际交流合作新格局等主题开展了广泛的交流。

To uphold the spirit of the 20th National Congress of the Communist Party of China and implement the directives of the Central Committee regarding drug regulation,the 6th China Drug Regulatory Science Conference was held by the China Society for Drug Regulation on April 1,2023,in Beijing.Under the guidance of the National Medical Products Administration and with strong support from relevant units,the conference centered on the theme"New Journey,New Tasks,New Opportunities-Regulatory Science Assists Regulatory Capacity Building and High-Quality Development".Representatives from relevant departments,affiliated units,and 30 provinces(districts,cities),as well as delegates from national pharmaceutical research institutions,universities,medical institutions,pharmaceutical enterprises,and related associations,participated in the conference.Experts engaged in extensive exchanges on topics such as comprehensively improving drug regulatory capabilities,promoting the high-quality development of the pharmaceutical industry,utilizing regulatory science to help build a strong country,providing services to ensure significant achievements in epidemic prevention and control,and building a new pattern of international cooperation.